Amgen’s Ian Thompson On Payer Shifts, Obesity Opportunity And The Future Of Blockbusters

Launches Have Longer Ramp-Up In High-Pressure Markets

 
• By Mandy Jackson
Close up of Amgen sign at its headquarters in Thousand Oaks, California, USA
Amgen's Enbrel is one of the first drugs under the IRA subject to Medicare negotiations • Source: Shutterstock

More from New Products

More from Scrip